Antheia

About:

A synthetic biology company for next generation plant-inspired medicines

Website: http://www.antheia.bio/

Top Investors: National Science Foundation, Silicon Valley Bank, Viking Global Investors, Hillspire, Irregular Expressions

Description:

Antheia is a biotechnology company unlocking the medicinal power of nature with its rapid response biomanufacturing processes for essential medicines. Antheia uses synthetic biology to surpass the limits of conventional drug manufacturing and discovery. By reconstructing complex molecules in yeast, Antheia can produce APIs without the use of medicinal plants, transforming the pharmaceutical supply chain and ensuring reliable, consistent, and widespread availability to essential medicines.

Total Funding Amount:

$152M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)antheia.bio

Founders:

Christina Smolke, Isis Trenchard, Kristy Hawkins

Number of Employees:

11-50

Last Funding Date:

2024-07-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai